APA

Tóth G., Szöőr Á., Simon L., Yarden Y., Szöllősi J. & Vereb G. (20171116). The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity. : mAbs.

Chicago

Tóth Gábor, Szöőr Árpád, Simon László, Yarden Yosef, Szöllősi János and Vereb György. 20171116. The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity. : mAbs.

Harvard

Tóth G., Szöőr Á., Simon L., Yarden Y., Szöllősi J. and Vereb G. (20171116). The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity. : mAbs.

MLA

Tóth Gábor, Szöőr Árpád, Simon László, Yarden Yosef, Szöllősi János and Vereb György. The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity. : mAbs. 20171116.